These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14658921)

  • 21. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of chronic idiopathic thrombocytopenic purpura in adults.
    Berchtold P; McMillan R
    Blood; 1989 Nov; 74(7):2309-17. PubMed ID: 2478227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
    Bengtson KL; Skinner MA; Ware RE
    J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
    Andersson PO; Wadenvik H
    Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis, pathophysiology and management of children with refractory immune thrombocytopenic purpura.
    Kalpatthi R; Bussel JB
    Curr Opin Pediatr; 2008 Feb; 20(1):8-16. PubMed ID: 18197033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura.
    Mahey R; Kaur SD; Chumber S; Kriplani A; Bhatla N
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24363245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.
    Cirasino L; Robino AM; Cattaneo M; Pioltelli PE; Pogliani EM; Terranova L; Morra E; Colombo P; Palmieri GA; Piscitelli P
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):77-84. PubMed ID: 19858712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M; Suvajdzic N; Colović N; Tomin D; Vidović A; Palibrk V
    Platelets; 2011; 22(2):153-6. PubMed ID: 21142405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?
    Cooper N; Evangelista ML; Amadori S; Stasi R
    Curr Opin Hematol; 2007 Nov; 14(6):642-6. PubMed ID: 17898569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency.
    Carbone J; Escudero A; Mayayo M; Ballesteros M; Perez-Corral A; Sanchez-Ramon S; Sarmiento E; Micheloud D; Fernandez-Cruz E
    Ann N Y Acad Sci; 2005 Jun; 1051():666-71. PubMed ID: 16127007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
    Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura.
    Provan D; Moss AJ; Newland AC; Bussel JB
    Am J Hematol; 2006 Jan; 81(1):19-25. PubMed ID: 16369979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab for the treatment of acute refractory ITP.
    Kim SG; Whyte D; Pashankar FD
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e149-51. PubMed ID: 23669737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current options for the treatment of idiopathic thrombocytopenic purpura.
    Arnold DM; Kelton JG
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of patients with chronic, refractory idiopathic thrombocytopenic purpura.
    George JN; Kojouri K; Perdue JJ; Vesely SK
    Semin Hematol; 2000 Jul; 37(3):290-8. PubMed ID: 10942223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
    Psaila B; Bussel JB
    Br J Haematol; 2008 Oct; 143(1):16-26. PubMed ID: 18573111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and outcomes of refractory immune thrombocytopenic purpura in children: a retrospective study in a single institution.
    Ito M; Yagasaki H; Kanezawa K; Shimozawa K; Hirai M; Morioka I
    Sci Rep; 2021 Jul; 11(1):14263. PubMed ID: 34253777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.
    De Mattia D; Del Vecchio GC; Russo G; De Santis A; Ramenghi U; Notarangelo L; Jankovic M; Molinari AC; Zecca M; Nobili B; Giordano P;
    Acta Haematol; 2010; 123(2):96-109. PubMed ID: 20029174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.